Company profile for Enochian BioSciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Based in Los Angeles, Enochian BioSciences Inc. is a gene-modified cell therapy company with a clear mission: develop definitive cures and provide effective prevention for infectious diseases and cancer. After the acquisition of Enochian Biopharma early 2018, Enochian Biosciences Inc. (former DanDrit Biotech USA Inc.) is poised to change the course of gene-modified cell therapy treatments through expert insights and dedicated ...
Based in Los Angeles, Enochian BioSciences Inc. is a gene-modified cell therapy company with a clear mission: develop definitive cures and provide effective prevention for infectious diseases and cancer. After the acquisition of Enochian Biopharma early 2018, Enochian Biosciences Inc. (former DanDrit Biotech USA Inc.) is poised to change the course of gene-modified cell therapy treatments through expert insights and dedicated efforts.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Century City Medical Plaza, 2080 Century Park East, Los Angels, CA 90067
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

BioProcess International US West

Not Confirmed

envelop Contact Supplier

BioProcess International US West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/06/08/2684768/0/en/Enochian-BioSciences-Announces-that-its-Cancer-Platform-Remains-on-Track-for-Trials-in-Humans-Following-FDA-Review.html

GLOBENEWSWIRE
08 Jun 2023

https://www.globenewswire.com/news-release/2023/04/03/2639669/0/en/Enochian-BioSciences-CEO-Letter-to-Shareholders.html

GLOBENEWSWIRE
03 Apr 2023

https://www.globenewswire.com/news-release/2023/03/29/2636755/0/en/Enochian-BioSciences-Announces-a-Scientific-Presentation-of-Proof-of-Concept-Studies-for-a-Potential-Therapy-for-Cancers-with-a-Poor-Life-Expectancy-by-a-Leading-Researcher.html

GLOBENEWSWIRE
29 Mar 2023

https://www.globenewswire.com/news-release/2023/03/13/2625713/0/en/Enochian-BioSciences-Achieves-Full-Compliance-with-NASDAQ-Filing-Requirements.html

GLOBENEWSWIRE
13 Mar 2023

https://www.globenewswire.com/news-release/2023/02/23/2614789/0/en/Enochian-BioSciences-Announces-Receipt-of-Notice-from-Nasdaq-Regarding-Delayed-Filing-of-Form-10-Q-for-the-Period-Ended-December-31-2022.html

GLOBENEWSWIRE
23 Feb 2023

https://www.globenewswire.com//news-release/2022/11/30/2565477/0/en/Enochian-BioSciences-Announces-Receipt-of-Notice-from-Nasdaq-Regarding-Delayed-Filing-of-Form-10-Q-for-the-Period-Ended-September-30-2022.html

GLOBENEWSWIRE
30 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty